Economic Impact of Obstructive Sleep Apnea
The American Academy of Sleep Medicine (AASM) commissioned a global research and consulting firm, Frost & Sullivan, to develop two reports related to the economic impact of obstructive sleep apnea (OSA) and the experience of adult sleep apnea patients in the United States. An editorial in the Journal of Clinical Sleep Medicine by AASM Past President Dr. Nathaniel Watson described the importance of these papers.
We encourage you to share these resources with patients, employers, policymakers and health care professionals.
Hidden Health Crisis Costing America Billions
This report combines a review of medical and economic literature with Frost & Sullivan’s modeling and forecasting to demonstrate the economic impact of undiagnosed and untreated OSA for payors, employers and patients. The report estimates that undiagnosed OSA cost the United States approximately $149.6 billion in 2015.
In an Age of Constant Activity, the Solution to Improving the Nation’s Health May Lie in Helping it Sleep Better
This report is based on a survey of 506 adults currently being treated for OSA in the U.S. The survey results and analysis describe the patient experience in detail and demonstrate the benefits that patients enjoy when obstructive sleep apnea is treated effectively.